Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database

被引：0
|
作者：
Kupczyk, Maciej [1 ]
Barg, Wojciech [2 ]
Bochenek, Grazyna [3 ]
Brozek, Grzegorz [4 ]
Brzostek, Dorota [5 ]
Dabrowiecki, Piotr [6 ]
Dabrowski, Andrzej [7 ]
Dobek, Rafal [8 ]
Gawlik, Radoslaw [9 ]
Kucharczyk, Aleksandra [10 ]
Kuprys-Lipinska, Izabela [1 ]
Mastalerz-Migas, Agnieszka [11 ]
Zagrajek, Edyta [12 ]
Kowalski, Marek L. [13 ]
机构：
[1] Med Univ Lodz, Dept Internal Med Asthma & Allergy, Lodz, Poland
[2] Med Univ Wroclaw, Dept Internal Med & Allergy, Wroclaw, Poland
[3] Jagiellonian Univ, Fac Med, Dept Internal Med, Sch Med, Krakow, Poland
[4] Med Univ Silesia, Sch Med Katowice, Dept Epidemiol, Katowice, Poland
[5] AstraZeneca Pharma Poland Sp Zoo, Warsaw, Poland
[6] Mil Inst Med, Dept Infect Dis & Allergol, Warsaw, Poland
[7] Warsaw Med Univ, Chair & Dept Internal Med Pneumonol & Allergol, Warsaw, Poland
[8] Inst TB & Lung Dis, Dept Lung Dis 2, Warsaw, Poland
[9] Med Univ Silesia, Div Dent Zabrze, Sch Med, Dept Internal Med Allergol & Clin Immunol, Katowice, Poland
[10] Mil Inst Med, Dept Internal Med Pneumonol Allergol & Clini Cal, Warsaw, Poland
[11] Wroclaw Med Univ, Dept Family Med, Wroclaw, Poland
[12] PEX PharmaSequence Sp Zoo, Warsaw, Poland
[13] Med Univ Lodz, Hlth Ageing Res Ctr, Chair Clin Immunol & Microbiol, Dept Immunol Rheumatol & Allergy, Lodz, Poland
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Exacerbation; Asthma; -; management; Pharmacology;
D O I：
10.1183/13993003.congress-2020.2638
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2638
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Predictors of excessive short-acting β2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database
    Kupczyk, Maciej
    Barg, Wojciech
    Bochenek, Grazyna
    Brozek, Grzegorz
    Dabrowiecki, Piotr
    Brzostek, Dorota
    Dabrowski, Andrzej
    Dobek, Rafal
    Gawlik, Radoslaw
    Kucharczyk, Aleksandra
    Kuprys-Lipinska, Izabela
    Mastalerz-Migas, Agnieszka
    Kowalski, Marek L.
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 790 - 797
  • [2] The history and future of short-acting beta2-agonist therapy in asthma
    Hills, Thomas
    Beasley, Richard
    [J]. RESPIROLOGY, 2020, 25 (03) : 246 - 248
  • [3] National expert consensus on short-acting beta2-agonist overreliance in asthma care in Malaysia
    Ban, Andrea Yu-Lin
    Taher, Sri Wahyu
    Muneswarao, Jaya
    Ho, Bee Kiau
    Ahmad, Rashidi
    Pereirasamy, Lalitha
    Chong, Li Yin
    Jamal, Shamsuriani Md
    Alaga, Arvindran
    Mydin, Helmy Haja
    Chang, Li Cheng
    Isa, Nor Azila Md
    Zim, Mohd Arif Mohd
    [J]. JOURNAL OF ASTHMA, 2024,
  • [4] EXPOSURE TO SYSTEMIC CORTICOSTEROIDS AMONG US PATENTS ASTHMA: RISKS ASSOCIATED WITH SHORT-ACTING BETA2-AGONIST USE
    Lanz, Miguel J.
    Pollack, Michael
    Gilbert, Ileen
    Gandhi, Hitesh N.
    Tkacz, Joseph
    Lugogo, Njira L.
    [J]. CHEST, 2022, 162 (04) : 48A - 49A
  • [5] Short-Acting Beta2-Agonist Use in Asthma in Korea: A 10-Year Population-Based Study
    Lee, Hyun
    Ryu, Jiin
    Chung, Sung Jun
    Yeo, Yoomi
    Park, Tai Sun
    Park, Dong Won
    Moon, Ji-Yong
    Kim, Tae-Hyung
    Sohn, Jang Won
    Yoon, Ho Joo
    Kim, Sang-Heon
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (06) : 945 - 953
  • [6] Developing a Smartphone Application That Promotes Responsible Short-Acting Beta2-Agonist Use in People with Asthma: A Participatory Design
    van den Berg, Liselot N.
    Hallensleben, Cynthia
    Chavannes, Niels H.
    Versluis, Anke
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (14)
  • [7] SHORT-ACTING BETA2-AGONIST USE REDUCTION AMONG PATIENTS WITH UNCONTROLLED ASTHMA USING A RELIEVER DIGITAL SYSTEM
    Hoyte, F.
    Mosnaim, G.
    Safioti, G.
    Brown, R.
    Hill, T.
    Boe, A.
    Li, T.
    Wechsler, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S40 - S40
  • [8] DIFFERENCES IN EXACERBATION PATTERNS AND SHORT-ACTING BETA2-AGONIST USE IN PATIENTS WITH MILD VS MODERATE/SEVERE ASTHMA
    Lugogo, N.
    Gilbert, I.
    Gandhi, H.
    Pollack, M.
    Surmont, F.
    Tkacz, J.
    Moore-Schiltz, L.
    Goshi, N.
    Lanz, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S32 - S32
  • [9] SHORT-ACTING BETA2-AGONIST AND SYSTEMIC/INHALED CORTICOSTEROID EXPOSURES IN US ADOLESCENTS AND ADULTS WITH ASTHMA
    Lanz, M.
    Pollack, M.
    Gilbert, I.
    Gandhi, H.
    Tkacz, J.
    Lugogo, N.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S54 - S55
  • [10] Assessing Asthma Control in the United States by Examining the Relationships Between Short-Acting Beta2-Agonist and Systemic Corticosteroid Use
    Bleecker, E. R.
    Murphy, K. R.
    Gandhi, H. N.
    Gilbert, I.
    Chupp, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345